Nov 10, 2025 04:01PM
Oct 23, 2025 06:33AM
Oct 22, 2025 07:30AM
Oct 22, 2025 07:30AM
Aug 11, 2025 04:01PM
Jun 30, 2025 11:00AM
Jun 30, 2025 11:00AM Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
Jun 23, 2025 08:30AM
May 12, 2025 04:01PM
Apr 11, 2025 06:37AM
Apr 10, 2025 08:00AM
Apr 10, 2025 08:00AM
Mar 10, 2025 06:44AM
Mar 10, 2025 05:14AM BTIG Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
Mar 6, 2025 04:01PM
Feb 18, 2025 06:47AM
Feb 3, 2025 06:39AM
Jan 6, 2025 04:01PM
Nov 11, 2024 04:01PM
Nov 11, 2024 04:01PM
Nov 7, 2024 04:01PM Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
Oct 2, 2024 06:44AM
Sep 4, 2024 06:53AM
Sep 3, 2024 08:33AM
Sep 3, 2024 08:30AM
Jul 1, 2024 04:01PM
Jul 1, 2024 04:01PM
Jun 7, 2024 10:32AM Arcturus Therapeutics (ARCT) Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference
Jun 7, 2024 10:30AM
May 28, 2024 06:30AM
May 28, 2024 06:30AM
Mar 7, 2024 04:01PM
Feb 22, 2024 08:31AM
Feb 22, 2024 08:30AM
Nov 27, 2023 08:31AM Arcturus Therapeutics (ARCT) Receives Orphan Drug Designation from the U.S. FDA for ARCT-032, for the Treatment of Cystic Fibrosis
Nov 27, 2023 08:30AM
Nov 14, 2023 04:01PM
Aug 7, 2023 04:01PM
Jun 1, 2023 08:30AM
Jun 1, 2023 08:30AM
May 12, 2023 08:45AM
Apr 21, 2022 06:14AM UPDATE: Citi Downgrades Arcturus Therapeutics (ARCT) to Neutral
Apr 20, 2022 07:31AM
Apr 20, 2022 07:30AM
Jan 18, 2022 07:00AM
Nov 8, 2021 04:00PM
Aug 10, 2021 09:25AM
Mar 1, 2021 04:01PM
Jan 4, 2021 07:02AM Arcturus Therapeutics (ARCT) Granted FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in U.S.
Jan 4, 2021 07:01AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All